What did our AI researcher identify regarding "sera prognostics nasdaqsera releases quarterly earnings results misses estima..."?

Sera Prognostics Q2 2026 EPS ($0.17) missed consensus ($0.16) by $0.01.

What other signal did our AI researcher identify regarding "sera prognostics nasdaqsera releases quarterly earnings results misses estima..."? (2)

Revenue $14,000, down from $38,000 year-over-year.

What other signal did our AI researcher identify regarding "sera prognostics nasdaqsera releases quarterly earnings results misses estima..."? (4)

Cash and securities $86.8 million, runway through 2029.

What other signal did our AI researcher identify regarding "sera prognostics nasdaqsera releases quarterly earnings results misses estima..."? (5)

Stock fell 3.7% to $1.81 after earnings.

tickerreport.com

www.tickerreport.com · May 7, 2026

Neutral

sera prognostics nasdaqsera releases quarterly earnings results misses estimates by 0 01 eps

TAX_ECON_PRICEAFFECTWB_1331_HEALTH_TECHNOLOGIESWB_1350_PHARMACEUTICALS

All News Read the full story on tickerreport.com

The full article is on the original publisher site. This page only shows the headline and a very short excerpt.

AI insight

AI-generated

Sera Prognostics is a small-cap diagnostics company with minimal revenue and ongoing losses. The earnings miss is minor ($0.01) and the stock decline is modest. No clear commercial mechanism beyond company-specific financial performance; no supply chain, scarcity, or sector-wide impact.

Signals our AI researcher identified

Extracted by our AI model from this article and related public sources — not direct quotes from the publisher.

Sera Prognostics Q2 2026 EPS ($0.17) missed consensus ($0.16) by $0.01.
Revenue $14,000, down from $38,000 year-over-year.
Net loss $8.4 million.
Cash and securities $86.8 million, runway through 2029.
Stock fell 3.7% to $1.81 after earnings.

Sector verdictGLOBAL_HEALTHCAREDownmagnitude 2/3 · confidence 2/5

Sera Prognostics stock down 1-2% in 48h following a minor EPS miss of $0.01.